PeerVoice Endocrinology & Metabolic Disorders Video

About PeerVoice Endocrinology & Metabolic Disorders Video

PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Endocrinology & Metabolic Disorders that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.

Publisher

PeerVoice

Category

education · health & fitness · science

Language

en

Explicit

No

First episode

24 May 2022

Latest episode

27 Aug 2026

Latest episodes

1 of 86 episodes have a transcript.

1. 

   27 Aug 2026

   Hannele Yki-Järvinen, MD, FRCP - Recognising and Referring Individuals With MASH: Practical Pathways for Our Endocrinology Practices

   For the complete activity, including supporting material, please visit https://www.peervoice.com/CTG860. Presented by Hannele Yki-Järvinen, MD, FRCP and Jeremy Tomlinson, MD, PhD, FRCP. Learning Objectives: Identify individuals who warrant evaluation for metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis based on the presence of cardiometabolic risk factors; Apply available non-invasive scoring systems such as the Fibrosis-4 (FIB-4) Index to predict presence of hepatic fibrosis; Use the outcomes of non-invasive tests to guide referral of individuals to specialist care for suspected MASH with fibrosis for additional workup and consideration for liver-directed therapy.

2. 

   14 Aug 2026

   Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand Eczema

   For the complete activity, including supporting material, please visit https://www.peervoice.com/MSG860. Presented by Raj Chovatiya, MD, PhD and Melinda Gooderham, MSc, MD, FRCPC. Learning Objectives: Identify the place in the treatment pathway of chronic hand eczema (CHE) for novel topical treatments; Explain criteria that inform clinical decisions on whether CHE is inadequately controlled on topical corticosteroids; Propose individualised evidence-based treatment strategies for patients with moderate-to-severe CHE that is inadequately controlled on topical corticosteroids.

3. 

   29 Jun 2026

   Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health

   For the complete activity, including supporting material, please visit https://www.peervoice.com/VAC860. Presented by Carel le Roux, MBChB, MSc, PhD; Biykem Bozkurt, MD, PhD; Domenica M. Rubino, MD; and Michael Donnelly-Boylen, MS. Learning Objectives: Describe the pathophysiologic relationship between obesity, metabolic dysfunction, and end-organ injury across cardiovascular, renal, and metabolic disease; Evaluate key clinical and psychosocial factors that influence multidisciplinary management decisions for patients with obesity and related cardiovascular-renal-metabolic disease; Apply evidence-based strategies to initiate and coordinate holistic, long-term weight management plans integrating nutrition, physical activity, behavioral, and pharmacologic interventions; Interpret the evolving rationale and design of emerging therapeutic approaches that target obesity as a root cause of multi-organ disease.

Inside a recent episode

David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?

Published 8 Nov 2025 · Transcript excerpt

[…] So we start eryoxicolic acid in every patient with PBC at a dose of 13 to 15 milligrams per kilogram per day. And the current approach is to assess the biochemical response at 12 months. If it's an adequate response, we continue the eryso indefinitely and if it's an inadequate response, the model is to add a second line therapy and then review response to that down the line. And a key part of this conversation is going to be the advent of new second line therapies. Now a key part of this is obviously the concept of eryoxicolic acid non -response. And one of the complications in the field is that there are a number of different criteria for this, all of which are variations of the same thing, which is ongoing elevation of alkaline phosphatase, ALT and bilirubin. […]

Who has been a guest on PeerVoice Endocrinology & Metabolic Disorders Video

Names identified in recent episode analyses. Showing up to five guests.

• Upender Mehan
• Emma Guttman-Yassky
• Richard David Graham Leslie
• Alice YY Cheng
• Gideon Hirschfield, MB BChir, FRCP, PhD

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

2 ratings

Podcast Authority Score: 27 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

22

Social presence

0

YouTube

0

Engagement

81

Questions about PeerVoice Endocrinology & Metabolic Disorders Video